Category Archive

Treatment (Pharmaceutical)

Epilepsy community encouraged to show support for proposed provincial strategy

June 21, 2012

Epilepsy Ontario is urging the epilepsy community to help end disparities in epilepsy care in the province. Many people living with uncontrolled seizures in Ontario do not get access to the medical services they require. To address the problem and help people access services, a panel of epilepsy experts, in conjunction with the Ontario Health…

Epilepsy community urged to alert MPs about drug-shortage issue

May 17, 2012

Are you affected by a drug shortage? Contact your health-care provider if your pharmacy is unable to fill your prescription. People with epilepsy should not make any changes to their treatment (i.e. skipping doses, reducing the dose, or discontinuing a drug) without consulting their health-care provider. Your physician or nurse practitioner can discuss the potential…

Groundbreaking epilepsy research project ‘unparalleled’ in clinical focus

April 19, 2012

OBI-funded project launches Deron Hamel The epilepsy research community is excited about the launch of an “unparalleled” project that will investigate improvements in clinical care for seizure disorders. Epilepsy Ontario board member and director of the University of Toronto Epilepsy Research Program Dr. Mac Burnham says the most exciting aspect of the research project, which…

Health Canada updates safety information for Trileptal (oxcarbazepine)

August 5, 2011

Health Canada Endorsed Important Safety Information on TRILEPTAL (oxcarbazepine): Association of TRILEPTAL (oxcarbazepine) with life-threatening dermatological reactions and multi-organ hypersensitivity In April 2005, Novartis Pharmaceuticals Canada Inc. distributed a letter to Canadian healthcare professionals concerning the updated consumer information for Trileptal tablets and oral suspension. Trileptal is used as a monotherapy or adjunctive therapy to…